VAP Prevention Bundle — Ventilator-Associated Pneumonia

Ventilator-associated pneumonia (VAP) prevention bundle for Georgian ICUs: head-of-bed elevation, sedation breaks, oral care, subglottic secretion drainage, and ventilator circuit management protocol.

Regulations › IPC Resources

Type
IPC Prevention Bundle
Scope
All Georgian ICUs and units managing mechanically ventilated patients
Source
WHO IPC core components; IHI Ventilator Bundle; ECDC VAP surveillance protocol
Publisher
PHIG Georgia
Updated
2025

Ventilator-associated pneumonia (VAP) is the most serious ICU-acquired infection — with attributable mortality of 20–30% and attributable ICU length of stay increase of 4–13 days per episode. Implementation of the VAP prevention bundle consistently reduces VAP rates by 40–65% in published evidence.[1][4] All Georgian ICUs managing mechanically ventilated patients must implement this bundle.

29.3%of healthcare-associated infections in EU/EEA hospitals are respiratory, including pneumoniaSource: ECDC PPS 2022–2023, via CIDRAP
4.3Mpatients a year acquire at least one healthcare-associated infection in EU/EEA hospitalsSource: ECDC
Dailysedation interruption and extubation assessment — every patientSource: VAP bundle

VAP prevention bundle — 5 core elements

#ElementStandardEvidence strength
1Head-of-bed elevation (HOB)Maintain HOB at 30–45° continuously for all mechanically ventilated patients[1] unless clinically contraindicated (haemodynamic instability, spinal precautions, prone positioning). Document actual angle daily. Supine position must be documented as physician order with specific clinical justification.Strong (Level 1A)
2Daily sedation vacation (SAT)Interrupt sedation infusion daily (unless patient fails safety screen); assess patient readiness; coordinate with spontaneous breathing trial (SBT). Reduces duration of ventilation and VAP risk. Document SAT attempt and outcome daily.Strong (Level 1A)
3Oral care with chlorhexidineOral decontamination with 0.12–0.2% chlorhexidine gluconate solution[1] — apply to oral mucosa every 2–4 hours; suction oropharyngeal secretions before repositioning; moisten oral mucosa hourly. Chlorhexidine oral rinse has strongest evidence; toothbrushing twice daily in addition.Strong (Level 1A)
4Subglottic secretion drainage (SSD)Use endotracheal tubes with subglottic secretion drainage port for all patients expected to require intubation for >48 hours; drain subglottic secretions every 2–4 hours by gentle suction. If SSD-capable ETT not available, continuous aspiration is preferred to intermittent.Strong (Level 1B)
5Spontaneous breathing trial and early extubationPerform SBT daily for all patients passing SAT safety screen; use low-level pressure support or T-piece for 30–120 minutes; extubate if patient passes SBT criteria; aim for earliest safe extubation. Document SBT result daily.Strong (Level 1A)

Additional ventilator care measures

MeasureStandard
Ventilator circuit changesDo NOT change circuits on a routine schedule; change only when visibly soiled or malfunctioning; heat-moisture exchangers (HME) changed every 5–7 days or when soiled; heated humidifiers: water changed every 24h with sterile water only
Closed suction systemsUse closed in-line suction catheters; change suction catheter per manufacturer guidance (typically every 24h); open suction only if closed system unavailable; sterile single-use catheter for each open suction episode
Cuff pressure managementMaintain ETT cuff pressure 20–30 cmH₂O; check every 8 hours with pressure manometer; higher pressures increase tracheal ischaemia risk; lower pressures allow aspiration of subglottic secretions around cuff
Stress ulcer prophylaxisProvide stress ulcer prophylaxis per local protocol (H2 blocker or PPI); but note: PPIs associated with higher VAP risk than H2 blockers — use lowest effective acid suppression
DVT prophylaxisProvide DVT prophylaxis for all mechanically ventilated patients; reduces pulmonary embolism risk; included in the IHI bundle

VAP diagnosis and surveillance

Key point

Clinical VAP diagnosis requires: mechanical ventilation for >48 hours AND new or progressive pulmonary infiltrate on chest X-ray AND at least 2 of: fever >38°C or hypothermia <36°C; leukocytosis >10,000 or leukopenia <4,000; new purulent endotracheal secretions; worsening oxygenation (PaO₂/FiO₂ ratio declining). Microbiological confirmation: quantitative BAL culture ≥10⁴ CFU/mL, protected specimen brush ≥10³ CFU/mL, or quantitative endotracheal aspirate ≥10⁵ CFU/mL. VAP rate = VAP episodes ÷ ventilator-days × 1,000 ventilator-days. Target: <2 VAP episodes per 1,000 ventilator-days in adult ICU.

In plain language

The VAP bundle reduces pneumonia in patients on mechanical ventilation through a few consistent measures: head-of-bed elevation, daily sedation review and weaning assessment, oral care and good management of the airway and equipment.

Why it matters

4.3Mpatients a year in EU/EEA hospitals acquire at least one healthcare-associated infectionSource: ECDC PPS 2022–2023
29.3%of healthcare-associated infections in EU/EEA hospitals were respiratory tract infections, including pneumoniaSource: ECDC PPS 2022–2023, via CIDRAP
Types of healthcare-associated infection, EU/EEA acute care hospitals 2022–2023 (% of all HAIs)
Respiratory tract29.3%
Urinary tract19.2%
Surgical site16.1%
Bloodstream11.9%
Gastrointestinal9.5%
Source: ECDC point prevalence survey 2022–2023, via CIDRAP

Key actions checklist

  • Elevate the head of the bed to 30–45 degrees unless contraindicated
  • Interrupt sedation daily and assess readiness to wean
  • Provide regular oral care
  • Manage endotracheal cuff pressure and subglottic secretions per protocol
  • Hand hygiene and aseptic handling of the circuit

International guidance

Questions and answers

Why daily sedation interruption?

It shortens ventilation time, which is the strongest risk factor for VAP.

How is success measured?

VAP rate per 1,000 ventilator-days and bundle compliance.

Georgian original source / ქართული წყარო

NCDC Georgia HAI and IPC Protocols — NCDC and GAPINCE

Open Georgian source →Additional reference →

NCDC Georgian-language HAI protocols. ECDC surveillance protocol for VAP in ICUs (English) — the European reference standard.

References

  1. [1] Klompas M, Branson R, Cawcutt K, et al. Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 Update. Infect Control Hosp Epidemiol. 2022;43(6):687–713. doi:10.1017/ice.2022.88
  2. [2] Tablan OC, Anderson LJ, Besser R, et al. Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep. 2004;53(RR-3):1–36. Available at: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5303a1.htm
  3. [3] Alhazzani W, Møller MH, Arabi YM, et al. Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med. 2020;46(5):854–887. doi:10.1007/s00134-020-06022-5
  4. [4] Institute for Healthcare Improvement (IHI). How-to Guide: Prevent Ventilator-Associated Pneumonia. IHI. 2012;—:—. Available at: https://www.ihi.org/resources/Pages/Tools/HowtoGuidePreventVentilatorAssociatedPneumonia.aspx
  5. [5] ECDC. Surveillance of Healthcare-Associated Infections in Intensive Care Units — Protocol version 2.2. European Centre for Disease Prevention and Control. 2017;—:—. Available at: https://www.ecdc.europa.eu/en/healthcare-associated-infections-intensive-care-units
  6. [6] WHO. Guidelines on Core Components of Infection Prevention and Control Programmes. World Health Organization. 2016;—:—. Available at: https://www.who.int/publications/i/item/9789241549929
PHIG Published by the Public Health Institute of Georgia (PHIG) · Regulations Hub · Contact PHIG